Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avant
New York, New York, United Statesavant.bio ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Avant Bio is a private early-stage and growth equity investment firm focused on life sciences, TechBio, healthtech, diagnostics, and therapeutic enabling technologies. Rather than developing its own drug pipeline, the firm backs companies working at the intersection of biology and advanced technology, including biomanufacturing tools, automation, machine learning, and AI applications for healthcare. The company positions itself around enabling next-generation therapeutic development and scaling the infrastructure behind modern biotech innovation. Avant Bio appears to be an active, women-founded firm headquartered in New York and led by founder Daniella Kranjac.
- Industry
- Investors
02
Partnerships
AbbelightIntrepid LabsNomic BioPathPresenterPrimaa
Beyond the preview
Go deeper on Avant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avant.